Inflammatory and Degenerative Muscle Disease

NCT ID: NCT05738590

Last Updated: 2023-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2024-05-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Correlation between clinical , ultrasonographical, neurophysiological and histopathological findings in muscle diseases of different etiologies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Muscle Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

inflammatory muscle disease

muscle biopsy

Intervention Type PROCEDURE

true cut needle biopsy

degenerative muscle disease

muscle biopsy

Intervention Type PROCEDURE

true cut needle biopsy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

muscle biopsy

true cut needle biopsy

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

neurophysiology(nerve conduction,electromyography) muscle ultrasound

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Muscle diseases of different etiologies.
2. Any age.

Exclusion Criteria

1. Patient refuse to participate.
2. The anatomy is altered due to severe trauma, tumor , or surgery.
3. Severe deformity preventing examination.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Huda Mahmoud Sayed Abdelal

Resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

huda mahmoud, Dr

Role: CONTACT

01119502695

Nageh Fouly kamal, Prof

Role: CONTACT

01003974403

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

muscle disease neurophysiology

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultrasound in Muscle Biopsy
NCT01790178 COMPLETED NA
Phrenic Identification in the ICU
NCT05875883 ACTIVE_NOT_RECRUITING
Imaging of Soft Tissues
NCT00796094 COMPLETED
Elastography and Treatment of Lymphoma
NCT05967975 NOT_YET_RECRUITING